News

Press Releases
Kane Biotech Announces Results of Special Meeting and Proposed Share Consolidation

WINNIPEG, Manitoba – December 16, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that a special resolution of the shareholders of the Corporation was passed at the special meeting of shareholders of the Corporation held…

> Read More

Press Releases
Kane Biotech Announces Shareholder Meeting to Consider Share Consolidation

WINNIPEG, Manitoba – November 25, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the Corporation has sent a notice of meeting, management information circular, proxy and related materials (the “Meeting Materials”) to its shareholders…

> Read More

Press Releases
Kane Biotech launches new branding for StrixNB oral health products for dogs and cats

WINNIPEG, Manitoba – October 19, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce the launch of new packaging and branding for StrixNBTM.

StrixNB is a premium line of oral health products designed to…

> Read More

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – September 28, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on September 28, 2016, it issued 256,600 common shares of the Corporation (“Common Shares”) in payment of $12,830 in interest owing on the Corporation’s $500,000…

> Read More

Press Releases
Kane Biotech Announces end of Joint Development Agreement and Appointment of Vice-President Sales

Kane Biotech Announces end of Joint Development Agreement and Appointment of Vice-President Sales

WINNIPEG, Manitoba – July 11, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the global animal health company with which it…

> Read More

Press Releases
Kane Biotech Announces Closing of Private Placement Offering and Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – June 29, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the Corporation has closed its previously announced private placement offering (the “Offering”) of common shares (“Common Shares”) at a price of…

> Read More

Press Releases
Kane Biotech Announces Grant of Options

Kane Biotech Announces Grant of Options

WINNIPEG, Manitoba – June 21, 2016 – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that the…

> Read More

Press Releases
Kane Biotech Announces Board Members

Kane Biotech Announces Board Members

WINNIPEG, Manitoba – June 6, 2016 – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that at the…

> Read More

Press Releases
Kane Biotech Announces Private Placement Offering and Proposed Consolidation of Shares

WINNIPEG, Manitoba – June 3, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced the intention of the Company to undertake a non-brokered private placement offering (the “Offering”) of up to 50,000,000 common shares (“Common Shares”)…

> Read More